Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas B Norgard

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Postgraduate Medicine|August 13, 2013
Clopidogrel, prasugrel, or ticagrelor? a practical guide to use of antiplatelet agents in patients with acute coronary syndromesNicholas B Norgard, James J Dinicolantonio
Recent Patents on Cardiovascular Drug Discovery|November 11, 2008
Future prospects in anti-platelet therapy: a review of potential P2Y12 and thrombin receptor antagonistsNicholas B Norgard, Mazen Abu-Fadel
Postgraduate Medicine|November 4, 2021
The rise of SGLT2 inhibitors: the time is now for cardiovascular specialists to lead the chargeNicholas B Norgard, Angel Lopez-Candales
Pharmacotherapy|June 26, 2008
Pharmacotherapy for heart failure with left ventricular dysfunction: beyond angiotensin-converting enzyme inhibitors and beta-blockersNicholas B Norgard, Jennifer E Stark
Current Clinical Pharmacology|December 15, 2015
Oral Administration of Sustained Release Niacin Inhibits Platelet AggregationNicholas B Norgard, Nicholas R Bacon, Matthew Agosti
The Annals of Pharmacotherapy|May 28, 2009
Drug-drug interaction between clopidogrel and the proton pump inhibitorsNicholas B Norgard, Kathryn D Mathews, Geoffrey C Wall
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 18, 2008
Cangrelor attenuates coated-platelet formationNicholas B Norgard, Callie L Hann, George L Dale
Postgraduate Medicine|June 9, 2023
Time to revisit the true role of metformin in type 2 diabetes mellitusAngel Lopez-Candales, Scott Monte, Khalid Sawalha, et al.
Cardiovascular Therapeutics|July 27, 2023
Heart Failure with Preserved Left Ventricular Ejection Fraction: A Complex Conundrum Simply Not Limited to Diastolic DysfunctionAngel Lopez-Candales, Talal Asif, Khalid Sawalha, et al.
Postgraduate Medicine|February 14, 2023
In search of mechanisms to explain the unquestionable benefit derived from sodium-glucose cotransporter-2 (SGLT-2) inhibitors use in heart failure patientsAngel Lopez-Candales, Khalid Sawalha, Betty M Drees, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Postgraduate Medicine|August 13, 2013
Clopidogrel, prasugrel, or ticagrelor? a practical guide to use of antiplatelet agents in patients with acute coronary syndromesNicholas B Norgard, James J Dinicolantonio
Recent Patents on Cardiovascular Drug Discovery|November 11, 2008
Future prospects in anti-platelet therapy: a review of potential P2Y12 and thrombin receptor antagonistsNicholas B Norgard, Mazen Abu-Fadel
Postgraduate Medicine|November 4, 2021
The rise of SGLT2 inhibitors: the time is now for cardiovascular specialists to lead the chargeNicholas B Norgard, Angel Lopez-Candales
Pharmacotherapy|June 26, 2008
Pharmacotherapy for heart failure with left ventricular dysfunction: beyond angiotensin-converting enzyme inhibitors and beta-blockersNicholas B Norgard, Jennifer E Stark
Current Clinical Pharmacology|December 15, 2015
Oral Administration of Sustained Release Niacin Inhibits Platelet AggregationNicholas B Norgard, Nicholas R Bacon, Matthew Agosti
The Annals of Pharmacotherapy|May 28, 2009
Drug-drug interaction between clopidogrel and the proton pump inhibitorsNicholas B Norgard, Kathryn D Mathews, Geoffrey C Wall
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 18, 2008
Cangrelor attenuates coated-platelet formationNicholas B Norgard, Callie L Hann, George L Dale
Postgraduate Medicine|June 9, 2023
Time to revisit the true role of metformin in type 2 diabetes mellitusAngel Lopez-Candales, Scott Monte, Khalid Sawalha, et al.
Cardiovascular Therapeutics|July 27, 2023
Heart Failure with Preserved Left Ventricular Ejection Fraction: A Complex Conundrum Simply Not Limited to Diastolic DysfunctionAngel Lopez-Candales, Talal Asif, Khalid Sawalha, et al.
Postgraduate Medicine|February 14, 2023
In search of mechanisms to explain the unquestionable benefit derived from sodium-glucose cotransporter-2 (SGLT-2) inhibitors use in heart failure patientsAngel Lopez-Candales, Khalid Sawalha, Betty M Drees, et al.
Pageof 3